WallStreetZenWallStreetZen

NASDAQ: SGMT
Sagimet Biosciences Inc Stock Ownership - Who owns Sagimet Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Sagimet Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
George KembleDirector2026-08-14326,618$6.36
$2.08MBuy
George KembleDirector2026-08-1424,369$6.36
$154.99kBuy
George KembleDirector2026-08-14350,987$10.23
$3.59MSell
George KembleDirector2026-08-1110,455$6.36
$66.49kBuy
George KembleDirector2026-08-1120,206$9.96
$201.15kSell
George KembleDirector2026-08-119,751$6.36
$62.02kBuy
Elizabeth RozekCLO2026-07-2010,545$7.76
$81.83kSell
David HappelCEO;Pres2026-07-2064,051$7.76
$497.10kSell
George KembleDirector2026-07-2018,844$7.46
$140.52kSell
David HappelPresident CEO2026-02-1012,101$5.36
$64.86kSell

1 of 2

SGMT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SGMT insiders and whales buy or sell their stock.

SGMT Shareholders

What type of owners hold Sagimet Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Patrick J. Kerins4.85%3,013,414$32.79MInsider
Forest Baskett4.84%3,011,575$32.77MInsider
Scott D. Sandell4.84%3,007,272$32.72MInsider
Nea Partners 13 Limited Partnership4.83%3,000,275$32.64MInsider
New Enterprise Associates 13 LP4.83%3,000,275$32.64MInsider
Beth C. Seidenberg3.27%2,031,118$22.10MInsider
Kpcb Pbd Associates LLC3.06%1,899,475$20.67MInsider
Jinzi Jason Wu2.66%1,654,701$18.00MInsider
David Happel1.19%741,570$8.07MInsider
Elizabeth Rozek0.36%224,414$2.44MInsider

1 of 3

SGMT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SGMT0.08%35.18%Net SellingNet Selling
PHAT0.09%41.37%Net SellingNet Selling
MDXG0.08%83.43%Net BuyingNet Selling
VSTM0.11%55.30%Net SellingNet Selling
DBVT0.01%11.36%Net SellingNet Selling
View Top Biotech Stocks

Sagimet Biosciences Stock Ownership FAQ

Who owns Sagimet Biosciences?

Sagimet Biosciences (NASDAQ: SGMT) is owned by 0.08% institutional shareholders, 35.18% Sagimet Biosciences insiders, and 64.74% retail investors. Patrick J. Kerins is the largest individual Sagimet Biosciences shareholder, owning 3.01M shares representing 4.85% of the company. Patrick J. Kerins's Sagimet Biosciences shares are currently valued at $32.79M.

If you're new to stock investing, here's how to buy Sagimet Biosciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.